Adoptive cell therapy across cancer diagnoses
收藏NIAID Data Ecosystem2026-03-10 收录
官方服务：
资源简介：
Primary objectives: The main objective is to determine the feasibility and safety of adoptive cell therapy in combination with checkpoint inhibition across different metastatic solid cancers. Primary endpoints: Toxicity: Registration of all AEs and unexpected events in relation to the treatment will be done in accordance with the common terminology criteria for adverse events (CTCAE) criteria as described in appendix 3.
创建时间：
2017-09-15
